stars 1 stars 2 stars 3

Cypre is a biotechnology company developing tumor organoid platforms to enable more predictive oncology. Our 3D organoids incorporate tumor, stromal, and immune components in high-throughput formats, built to replace animal models and better capture complex mechanisms of action (MOA). Cypre’s platform supports immunotherapy development through functional insight, MOA analytics, and emerging biomarker discovery, accelerating the path toward precision medicine.

Cypre Inc. Questions

The Cypre Inc. annual revenue was $7 million in 2026.

Kolin Hribar is the CEO and Founder of Cypre Inc..

3 people are employed at Cypre Inc..

Cypre Inc. is based in San Francisco, California.

The NAICS codes for Cypre Inc. are [541, 54171, 541714, 5417, 54].

The SIC codes for Cypre Inc. are [873, 87].

Top Cypre Inc. Employees

View Similar People
G2 Leader Summer 2026 G2 Best Est ROI Mid-Market Summer 2026 G2 Easiest Admin Mid-Market Summer 2026 G2 Most Implementable Summer 2026 G2 Best Results Mid-Market Summer 2026 G2 Lead Capture Mid-Market Summer 2026 Inc Fastest Growing Private Companies 2026 Inc Best Workplace 2026
g2crowd
G2Crowd Trusted
chromestore
300K+ Plugin Users